Clinical Pharmacology Case Analysis
6 weeks · 0 milestones
Apply pharmacological knowledge to a real or realistic clinical case. Proof requires a written case analysis covering: therapeutic objectives for the specific case, drug selection rationale (why this drug class over the alternatives), dose optimisation considerations (renal/hepatic adjustment, weight-based dosing if applicable), monitoring parameters, and patient counselling points. The case must specify a named drug and named clinical indication — generic analyses are not accepted. Reviewed by a clinical pharmacologist or senior pharmacist who challenges at least one decision in the analysis with a follow-up question the student must answer in real time. The proof is a supervised learning exercise, not a prescription to be implemented.
Milestone map
Milestone map
3 milestones
Select two major drug classes from your curriculum or clinical area (e.g. ACE inhibitors + beta blockers, or SSRIs + antipsychotics). For each class, build a pharmacology reference map covering: mechanism of action at the receptor/molecular level, major clinical indications, contraindications and cautions, common adverse effects and their mechanisms, key drug interactions (pharmacokinetic and pharmacodynamic), and monitoring requirements. This is knowledge organisation to prepare for the case analysis milestones.
Proof required
Submit your pharmacology maps for both classes. Include a note on your primary reference source for each map.
What gets checked
- Mechanism of action is described at the molecular/receptor level — 'lowers blood pressure' is an effect, not a mechanism.
- Drug interactions section distinguishes pharmacokinetic interactions (affecting absorption, distribution, metabolism, excretion) from pharmacodynamic interactions (additive effects at receptor level).
- Adverse effects are linked to their mechanism — 'ACE inhibitors cause cough because...' not just 'ACE inhibitors cause cough'.